Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23.63%677.08M | 16.91%638.42M | 8.58%517.63M | 9.11%2.2B | 15.31%627.32M | 1.39%547.67M | 16.17%546.08M | 3.64%476.75M | -19.90%2.01B | 4.42%544.03M |
| Cost of revenue | 27.91%742.63M | -36.14%580.59M | ||||||||
| Gross profit | 1.50%1.46B | -10.71%1.43B | ||||||||
| Operating expense | 40.53%401.26M | 2.77%324.8M | -0.75%303.92M | 4.79%562.13M | -18.52%-345.69M | 17.79%285.54M | 17.71%316.05M | -3.47%306.23M | -31.37%536.46M | 49.84%-291.68M |
| Staff costs | ---- | ---- | ---- | 0.62%244.96M | ---- | ---- | ---- | ---- | 6.89%243.46M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 2.43%109.57M | ---- | ---- | ---- | ---- | 4.13%106.97M | ---- |
| -Depreciation | ---- | ---- | ---- | 2.43%109.57M | ---- | ---- | ---- | ---- | 4.13%106.97M | ---- |
| Other operating expenses | 28.26%409.66M | 3.19%342.34M | -0.54%309.49M | -6.57%259.7M | -9.36%-702.64M | 31.76%319.4M | 2.32%331.76M | -12.96%311.18M | -40.54%277.95M | 29.73%-642.52M |
| Total other operating income | -75.17%8.41M | 11.68%17.55M | 12.49%5.58M | -43.32%52.1M | -494.85%-2.43M | --33.86M | -71.81%15.71M | -87.70%4.96M | 464.66%91.93M | 83.41%-408K |
| Operating profit | 5.22%275.82M | 36.35%313.63M | 25.33%213.71M | -0.46%893.05M | -9.70%230.37M | -11.96%262.13M | 14.11%230.03M | 19.45%170.52M | 8.90%897.2M | 32.01%255.12M |
| Net non-operating interest income (expenses) | -28.51%3.9M | -24.88%4.54M | -18.57%5.62M | -10.45%23.1M | -31.32%4.7M | -4.85%5.46M | -12.83%6.04M | 9.76%6.91M | 177.79%25.79M | 30.31%6.84M |
| Non-operating interest income | -29.75%3.91M | -24.85%4.55M | -18.53%5.63M | -9.78%23.94M | -23.06%5.42M | -5.95%5.57M | -14.91%6.05M | 6.81%6.91M | 128.85%26.54M | 18.24%7.04M |
| Non-operating interest expense | -92.59%8K | -10.00%9K | 12.50%9K | 13.39%847K | 255.17%721K | -40.66%108K | -94.48%10K | -95.58%8K | -67.69%747K | -71.29%203K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -78.28%2.88M | 248.09%10.94M | 202.45%3.09M | 116.45%22.73M | -37.05%5.3M | 445.56%13.27M | 334.30%3.14M | 3.13%1.02M | -21.03%10.5M | -18.57%8.42M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 0.62%282.61M | 37.58%329.1M | 24.64%222.42M | 0.58%938.88M | -11.10%240.37M | -8.19%280.86M | 15.46%239.21M | 18.94%178.45M | 10.28%933.49M | 29.47%270.37M |
| Income tax | 20.09%78.1M | 50.56%78.4M | 29.06%57.97M | -1.35%219.47M | -16.15%57.45M | -6.03%65.04M | 10.38%52.07M | 19.53%44.91M | -7.66%222.47M | 43.66%68.52M |
| Net income | -5.24%204.5M | 33.97%250.7M | 23.16%164.46M | 1.18%719.41M | -9.38%182.92M | -8.82%215.82M | 16.96%187.13M | 18.74%133.54M | 17.41%711.02M | 25.26%201.86M |
| Net income continuous operations | -5.24%204.5M | 33.97%250.7M | 23.16%164.46M | 1.18%719.41M | -9.38%182.92M | -8.82%215.82M | 16.96%187.13M | 18.74%133.54M | 17.41%711.02M | 25.26%201.86M |
| Noncontrolling interests | 55.25%1.23M | 10.68%1.33M | 80.24%1.2M | 33.17%4.33M | 91.54%1.68M | -22.90%791K | 22.24%1.2M | 79.67%663K | -16.24%3.25M | 71.91%875K |
| Net income attributable to the company | -5.47%203.28M | 34.12%249.38M | 22.87%163.26M | 1.03%715.08M | -9.82%181.24M | -8.76%215.03M | 16.93%185.94M | 18.54%132.87M | 17.63%707.77M | 25.12%200.98M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -5.47%203.28M | 34.12%249.38M | 22.87%163.26M | 1.03%715.08M | -9.82%181.24M | -8.76%215.03M | 16.93%185.94M | 18.54%132.87M | 17.63%707.77M | 25.12%200.98M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.47%0.3267 | 34.14%0.4008 | 22.85%0.2624 | 0.58%1.1467 | -11.31%0.2887 | -8.76%0.3456 | 16.90%0.2988 | 18.58%0.2136 | 17.93%1.14 | 26.25%0.3255 |
| Diluted earnings per share | 0 | 0 | 22.85%0.2624 | 0.88%0.7667 | -10.64%0.2887 | 0 | 0 | 18.58%0.2136 | -21.38%0.76 | 25.30%0.323 |
| Dividend per share | 0 | 0.71%0.47 | 0 | 0.00%0.7333 | 0.00%0.2667 | 0 | 0.00%0.4667 | 0 | 4.76%0.7333 | 0.00%0.2667 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.